HawkScreener
Register Sign In
Dashboard Screener Heatmap Compare Sign In

STZ

Constellation Brands, Inc. (S&P 500)

Consumer Defensive — Beverages - Brewers

Constellation Brands, Inc., together with its subsidiaries, produces, imports, markets, and sells beer, wine, and spirits in the United States, Canada, Mexico, New Zealand, and Italy. It offers beer under the Corona Extra, Corona Familiar, Corona Sunbrew, Corona Light, Corona Non-Alcoholic, Corona Premier, Modelo Especial, Modelo Chelada, Modelo Negra, Modelo Spiked Aguas Frescas, Modelo Oro, Modelo Noche Especial, Victoria, Vicky Chamoy, and Pacifico brand names. The company also offers wine under the Sea Smoke, Schrader Cellars, Kim Crawford, Mount Veeder, Ruffino, My Favorite Neighbor, Robert Mondavi Winery, and The Prisoner Wine Company brand names; and spirits under the Casa Noble, High West, Mi CAMPO, and Nelson's Green Brier brand names. It provides its products to wholesale distributors, retailers, and state alcohol beverage control agencies. Constellation Brands, Inc. was founded in 1945 and is headquartered in Rochester, New York.

Buy 2.0 / 5 23 analysts
$132.02
+$2.31 (+1.78%)
Target: $170.83 (29.4%)
Sign in to add STZ to a watchlist or set price alerts.

Price History

52-Week Range

Fundamentals

Market Cap$22.55B
P/E Ratio (TTM)12.59
Forward P/E10.65
EPS (TTM)$10.49
Dividend Yield3.18%
Profit Margin20.14%
Revenue Growth-3.30%
ROE23.69%
Debt/Equity123.21
Recommendation Buy 2.0
Analyst Target$170.83
Analysts23
Indexes S&P 500

Technical Indicators

RSI (14)53.0
Beta0.38
SMA 20$132.85
SMA 40$137.24
52-Week High$176.33
52-Week Low$126.45
50-Day Avg$139.17
200-Day Avg$145.53
Avg Volume$2.21M
Volume$1.86M

Performance Analysis

BULLISH

STZ shows predominantly bullish signals based on its fundamentals and technicals.

~ Trading at 11% of its 52-week range.
~ RSI at 53.0 is in neutral territory.
- Price is below both the 50-day and 200-day moving averages — in a downtrend.
+ P/E of 12.6 suggests the stock may be undervalued.
- Revenue declined 3.3% year-over-year.
+ Healthy profit margin of 20.1%.
+ Wall Street consensus is "Buy" from 23 analysts.
+ Average analyst target of $170.83 implies 29.4% upside.

Recent News

Loading news...
Sign in for full analysis Unlock insider trading data, options chain, news feed, and more.
Sign In

Last updated: Jul 28, 2026 21:01 UTC

Back to Screener Export Report